Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Tracer in Laparoscopic Gastrectomy for Remnant Gastric Cancer
NCT05618821Phase 2Recruiting
- Sponsor
- Fujian Medical University
- Start
- Jun 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of indocyanine green in gastric cancer (GC) (2 arms), sponsored by Fujian Medical University. Primary endpoint: Total Number of Retrieved Lymph Nodes at 30 days. Started Jun 2022; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05618821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05618821.